发布求助
文献互助 智能选刊 最新文献

Journal of Medical Toxicology最新文献

筛选
英文 中文
Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin". 评论“苯妥英处理他克莫司与Nirmatrelvir/Ritonavir (Paxlovid™)的药物相互作用”。
IF 2.9 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 DOI: 10.1007/s13181-023-00936-4
Luciana Mello de Oliveira, Tatiane da Silva Dal Pizzol
{"title":"Comment on \"Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin\".","authors":"Luciana Mello de Oliveira, Tatiane da Silva Dal Pizzol","doi":"10.1007/s13181-023-00936-4","DOIUrl":"https://doi.org/10.1007/s13181-023-00936-4","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9696998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keeping Safe and Effective Medications Accessible. 保持安全有效的药物可及性。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-26 DOI: 10.1007/s13181-023-00949-z
Maryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach
{"title":"Keeping Safe and Effective Medications Accessible.","authors":"Maryann Mazer-Amirshahi, Peggy Ye, Andrew Stolbach","doi":"10.1007/s13181-023-00949-z","DOIUrl":"10.1007/s13181-023-00949-z","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293496/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10064675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies. 药品采购：现状回顾及对解毒疗法的影响。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-30 DOI: 10.1007/s13181-023-00943-5
Andrew Troger, Michele M Burns
{"title":"Pharmaceutical Purchasing: a Review of the Landscape and Implications for Antidotal Therapies.","authors":"Andrew Troger, Michele M Burns","doi":"10.1007/s13181-023-00943-5","DOIUrl":"10.1007/s13181-023-00943-5","url":null,"abstract":"<p><p>The management of the poisoned patient often requires the utilization of uncommonly used pharmaceutical interventions. These interventions can be associated with significant costs to both the patient and treating institution. Pharmaceutical supply shortages and issues with accessibility of antidotal therapies complicate the management of many toxic exposures. These challenges are an inherent property of the pharmaceutical purchasing infrastructure in the United States, which is a complicated network of public and private intra-institutional agreements. The cost and availability of any given therapy is dependent on the individual contracting agreements between the treating institution, payer, pharmacy benefit manager, manufacturer or wholesaler, and in some cases a specialty pharmacy. Small or remote hospitals may experience greater challenges related to insufficient patient volume to achieve predicable prescribing patterns of rare and expensive medications, necessitating consignment purchasing arrangements. Although pharmaceutical costs are the focus of recent legislative attention, these reforms are not expected to significantly alter the cost or availability of antidotal therapies.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293135/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACMT Position Statement: End the Use of the Term "Excited Delirium". ACMT 立场声明：停止使用 "兴奋性谵妄 "一词。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-22 DOI: 10.1007/s13181-023-00944-4
Andrew I Stolbach, Paul I Dargan, Howard A Greller, Richard J Hamilton, Kelly Johnson-Arbor, Brian Patrick Murray, Daniel Ovakim, Laura Tormoehlen, Lewis S Nelson
{"title":"ACMT Position Statement: End the Use of the Term \"Excited Delirium\".","authors":"Andrew I Stolbach, Paul I Dargan, Howard A Greller, Richard J Hamilton, Kelly Johnson-Arbor, Brian Patrick Murray, Daniel Ovakim, Laura Tormoehlen, Lewis S Nelson","doi":"10.1007/s13181-023-00944-4","DOIUrl":"10.1007/s13181-023-00944-4","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293509/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10070033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rate of Adverse Outcomes During 6-Hour Observation for Asymptomatic Patients with Select Ingestions. 对无症状的特定误食患者进行 6 小时观察期间的不良后果发生率。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-09 DOI: 10.1007/s13181-023-00954-2
Michael Keenan, Stephen Rice, Emma Frawley, Chelsie Jacques, Susan Wojcik, Jeanna Marraffa
{"title":"Rate of Adverse Outcomes During 6-Hour Observation for Asymptomatic Patients with Select Ingestions.","authors":"Michael Keenan, Stephen Rice, Emma Frawley, Chelsie Jacques, Susan Wojcik, Jeanna Marraffa","doi":"10.1007/s13181-023-00954-2","DOIUrl":"10.1007/s13181-023-00954-2","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293546/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9762354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rivastigmine Use in the Treatment of Antimuscarinic Delirium. 使用利凡斯的明治疗抗心律失常谵妄。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-19 DOI: 10.1007/s13181-023-00947-1
Spencer C Greene
{"title":"Rivastigmine Use in the Treatment of Antimuscarinic Delirium.","authors":"Spencer C Greene","doi":"10.1007/s13181-023-00947-1","DOIUrl":"10.1007/s13181-023-00947-1","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293131/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10083271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to Comment on "Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin". 对“苯妥英处理他克莫司与Nirmatrelvir/Ritonavir (Paxlovid™)药物相互作用”评论的回应。
IF 2.9 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 DOI: 10.1007/s13181-023-00940-8
Morganne Sindelar, Daniel McCabe, Elisabeth Carroll
{"title":"Response to Comment on \"Tacrolimus Drug-Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin\".","authors":"Morganne Sindelar,&nbsp;Daniel McCabe,&nbsp;Elisabeth Carroll","doi":"10.1007/s13181-023-00940-8","DOIUrl":"https://doi.org/10.1007/s13181-023-00940-8","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.9,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054203/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9694409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Taste Additives on the Palatability of Activated Charcoal: a Systematic Review. 添加剂对活性炭适口性的影响：系统综述
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-03-31 DOI: 10.1007/s13181-023-00934-6
Elisabeth Canitrot, Alexis F Turgeon, Lynne Moore, Ella Diendéré, Maude St-Onge
{"title":"Effect of Taste Additives on the Palatability of Activated Charcoal: a Systematic Review.","authors":"Elisabeth Canitrot, Alexis F Turgeon, Lynne Moore, Ella Diendéré, Maude St-Onge","doi":"10.1007/s13181-023-00934-6","DOIUrl":"10.1007/s13181-023-00934-6","url":null,"abstract":"<p><strong>Introduction: </strong>Activated charcoal is a decontaminating agent used for acute intoxication. It can be mixed with taste additives to overcome its poor palatability. Our purpose was to evaluate the taste additives used to improve activated charcoal's palatability.</p><p><strong>Methods: </strong>We conducted a systematic review of comparative studies on taste additives used to improve activated charcoal's palatability. We searched PubMed, Embase, Web of Science, Cochrane, and CINAHL. We included controlled trials and observational studies that evaluate the effect of at least one taste additive, compared with activated charcoal alone. Our primary outcome was palatability. Our secondary outcomes included treatment adherence, adsorption efficacy, and adverse events. The risk of bias was assessed using the Quality Assessment Tool for Quantitative Studies.</p><p><strong>Results: </strong>Among 38 eligible articles, seven observational studies and three crossover clinical trials met our inclusion criteria. The risk of bias was found to be high for seven studies and intermediate for three others. The preferred flavoring agents were cola and chocolate milk for children, and sweetening agents for adults. All taste additives studied seemed to improve activated charcoal's palatability, except for yogurt (n = 1). The addition of bentonite, sorbitol, carboxymethylcellulose, or yogurt showed no impact on the in-vivo adsorption capacity of activated charcoal, whereas the results were inconclusive for chocolate. No meta-analysis was performed due to insufficient data.</p><p><strong>Conclusion: </strong>Strategies to improve activated charcoal's palatability seem to enhance the taste. Descriptive data are in favor of a limited impact on activated charcoal's adsorption capacity when adding binding agents or sweeteners.</p><p><strong>Trial registration on prospero: </strong>This review is registered as PROSPERO CRD42019135092.</p>","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9696876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug Shortages Negatively Impact Health Systems and Bedside Patient Care. 药物短缺对医疗系统和床边病人护理造成负面影响。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-06-02 DOI: 10.1007/s13181-023-00950-6
Joanne C Routsolias, Ashley N Webb
{"title":"Drug Shortages Negatively Impact Health Systems and Bedside Patient Care.","authors":"Joanne C Routsolias, Ashley N Webb","doi":"10.1007/s13181-023-00950-6","DOIUrl":"10.1007/s13181-023-00950-6","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293503/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9707021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ToxRunner: the Development of a Non-commercial Mobile Digital Question Bank for the Graduate Medical Education Sub-specialty of Medical Toxicology. ToxRunner：为医学毒理学研究生教育分专业开发非商业性移动数字题库。
IF 2.5 4区 医学
Journal of Medical Toxicology Pub Date : 2023-07-01 Epub Date: 2023-05-26 DOI: 10.1007/s13181-023-00952-4
Adam Blumenberg
{"title":"ToxRunner: the Development of a Non-commercial Mobile Digital Question Bank for the Graduate Medical Education Sub-specialty of Medical Toxicology.","authors":"Adam Blumenberg","doi":"10.1007/s13181-023-00952-4","DOIUrl":"10.1007/s13181-023-00952-4","url":null,"abstract":"","PeriodicalId":16429,"journal":{"name":"Journal of Medical Toxicology","volume":null,"pages":null},"PeriodicalIF":2.5,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293127/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10083803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信